Evaluating potential agents to prevent cancer
Official title: Contract Orientation and Kickoff Meeting
Funded at University of Illinois at Chicago · NIH-11032070 · Data updated 2026-11-12
This study is looking at different potential treatments that might help prevent cancer, and it's designed to find safe and effective options that could benefit patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project start | January 25, 2024 |
| Project end | February 24, 2029 |
| Funding year | 2024 |
| Award (this year) | $3,500 |
| NIH project number | 75N91024D00002-0-759102400001-1 |
| Project ID | NIH-11032070 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at high risk for cancer or those interested in preventive measures against cancer.
✕Less likely to help
Patients who are currently diagnosed with cancer or those who do not have a family history of cancer may not receive direct benefits from this research.
What this research studies
This research focuses on assessing the pharmacological and toxicological effects of various potential cancer preventive agents. By utilizing resources from contracts, the study aims to support the development of multiple candidate agents that could help in cancer prevention. Patients may benefit from this research as it seeks to identify effective strategies to reduce cancer risk through innovative treatments. The approach involves rigorous testing and evaluation to ensure safety and efficacy.
Why it matters
Potential benefit: If successful, this research could lead to new preventive treatments that significantly lower the risk of developing cancer.
How similar studies have gone: Previous research has shown promise in evaluating cancer preventive agents, indicating that this approach has potential for success.
Where this research is happening
-
University of Illinois at Chicago
Chicago, United States Active
Researchers
- Principal investigator: Lyubimov, Alexander V — University of Illinois at Chicago
- Study coordinator: Lyubimov, Alexander V
Related research
Other NIH-funded projects on the same topics.
-
MSC Secretome Eye Drops to Speed Healing of Corneal Wounds
A new eye drop made from stem cell–secreted factors is being tested to help adults with non-healing corneal wounds recover vision faster.
-
UIC Center for Healthy Work
A national program led by UIC aims to improve the health and well-being of workers through collaborative research and practical solutions.
-
Coordinated Oral Health Promotion for Chicago Kids
A long-running study in Chicago is following children and their caregivers to find ways to reduce tooth decay and improve daily life for families.
-
Targeting p38 MAPK to slow ALS-related axonal damage
Aims to block a specific brain-wide signaling pathway (p38 MAPK) to reduce nerve damage in people with various genetic forms of ALS.
-
Precision nanomedicine to calm inflammation and protect bone in gum disease
A new, targeted nanomedicine approach aims to reduce gum inflammation and prevent bone loss in adults with periodontal disease.
-
Role of DPP in Dental Pulp Stem Cells and their Regenerative Potential
A project explores how a natural tooth protein helps dental pulp stem cells repair and regenerate the tooth’s inner tissue.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.